Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 22, 2015 10:15 PM ET

Pharmaceuticals

Company Overview of Sihuan Pharmaceutical Holdings Group Ltd.

Company Overview

Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, researches and develops, manufactures, and sells pharmaceutical products in the People’s Republic of China. The company offers various cardio-cerebral vascular drugs, such as Oudimei to treat dysfunction caused by cardiac and brain diseases; Kelinao/Anjieli/Qingtong to treat cardio, cerebro, and peripheral vascular diseases; Yuanzhijiu to treat cardio-cerebral vascular diseases; GM1 to treat traumatic brain injuries, cerebral vascular accidents, and Parkinson’s disease; Guhong to treat cerebrovascular problems; and Yimaining to treat chronic arteriosclerosis obliterans, unstable angina, myocardial infarction, coronary ...

Zhubang 2000 Business Centre

Building 2, 21st Floor

West Balizhuang

Chaoyang District

Beijing,  10025

China

Founded in 2001

2,726 Employees

Phone:

86 10 5227 8700

Fax:

86 10 5227 8758

Key Executives for Sihuan Pharmaceutical Holdings Group Ltd.

Deputy Chairman, Chief Executive Officer and Member of Nomination Committee
Age: 50
Total Annual Compensation: $16.0M
Co-Founder, Executive Chairman and Member of Remuneration Committee
Age: 52
Total Annual Compensation: $26.8M
Deputy General Manager of Sales & Marketing and Executive Director
Age: 50
Total Annual Compensation: $10.5M
Compensation as of Fiscal Year 2013.

Sihuan Pharmaceutical Holdings Group Ltd. Key Developments

Sihuan Pharmaceutical Holdings Group Ltd. Announces Delay in Publication of 2014 Annual Results

The Board of Sihuan Pharmaceutical Holdings Group Ltd. announced the shareholders of the company that the company is not able to publish the 2014 annual results on 31 March 2015 due to the fact that the auditors will not complete their audit of the company's financial statements in sufficient time.

Sihuan Pharmaceutical Holdings Group Ltd. to Report Fiscal Year 2014 Results on Mar 31, 2015

Sihuan Pharmaceutical Holdings Group Ltd. announced that they will report fiscal year 2014 results on Mar 31, 2015

Sihuan Pharmaceutical Holdings Group Ltd., Board Meeting, Mar 31, 2015

Sihuan Pharmaceutical Holdings Group Ltd., Board Meeting, Mar 31, 2015., at 11:00 China Standard Time. Agenda: To consider and approve the annual results of the Company and its subsidiaries for the year ended December 31, 2014; and to consider the recommendation of the payment of final dividend.

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Sihuan Pharmaceutical Holdings Group Ltd., please visit www.sihuanpharm.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.